Driving clinical research and progress of neurotransformational therapeutics

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin

Emmanuelle A. D. Schindler1,2,3 & R. Andrew Sewell4,5 & Christopher H. Gottschalk3 & Christina Luddy4,5 &L. Taylor Flynn4,5 & Hayley Lindsey1,2,3 & Brian P. Pittman4 & Nicholas V. Cozzi6,7 & Deepak C. D’Souza4,5 . October 27, 2020

Psychoactive Substances as a Last Resort—a Qualitative Study of Self-Treatment of Migraine and Cluster Headaches

Martin Andersson, Mari Persson & Anette Kjellgren. Harm Reduction Journal volume 14, Article number: 60 (2017)

Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey

Emmanuelle A. D. Schindler, M.D., Ph.D., Christopher H. Gottschalk , M.D., Marsha J. Weil, Robert E. Shapiro , M.D., Douglas A. Wright , D.C. & Richard Andrew Sewell , M.D. Journal of Psychoactive Drugs Volume 47, 2015 – Issue 5

Psilocybin and Obsessive Compulsive Disorder  

James Allen Wilcox. J Psychoactive Drugs Nov-Dec 2014;46(5):393-5. doi:10.1080/02791072.2014.963754.

Serotonergic and Dopaminergic Distinctions in the Behavioral Pharmacology of(±)-1-(2,5-Dimethoxy-4-iodophenyl)-2-Aminopropane (DOI) and Lysergic Acid diethylamide (LSD)

Emmanuelle A.D. Schindler ⁎, Kuldip D. Dave, Elaine M. Smolock, Vincent J. Aloyo, John A. Harvey. Pharmacology, Biochemistry and Behavior 101 (2012) 69–76

The Non-Hallucinogen 2-Bromo-lysergic Acid Diethylamide as Preventative Treatment for Cluster Headache: An Open, Non-Randomized Case Series

Matthias Karst, John H, Halpern, Michael Bernateck, Torsten Passie. Cephalalgia. 2011 Apr; 31(5):634.

Response of Cluster Headache to Psilocybin and LSD

R. Andrew Sewell, MD; John H. Halpern, MD; and Harrison G. Pope, Jr., MD. Neurology June 27, 2006; 66(12)

Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder 

Francisco A Moreno 1, Christopher B Wiegand, E Keolani Taitano, Pedro L Delgado J Clin Psychiatry. 2006 Nov;67(11):1735-40. doi: 10.4088/jcp.v67n1110.

Cholinesterase, Dlysergic Acid Diethylamide, and 2-Bromolysergic Acid Diethylamide

J R BERTINO, G D KLEE, W WEINTRAUB J Clin Exp Psychopathol Q Rev Psychiatry Neurol. Jul-Sep 1959;20:218-22.

Role of 5-Hydroxytryptamine in Mental Diseases and its Antagonism to Lysergic Acid Derivatives

A.CERLETTI & E. ROTHLIN  Nature October 22, 1955

Ceruvia Lifesciences

Transformational Medicines for Neurological & Psychiatric Disorders